• Profile
Close

Salvage radiotherapy improves survival in patients with locoregionally relapsed stage IE–IIE extranodal natural killer/T-cell lymphoma, nasal type

Therapeutics and Clinical Risk Management Jun 13, 2018

Tong Q, et al. - Researchers retrospectively examined the salvage treatment outcomes and prognostic factors in patients with early stage locoregionally recurrent (LRR) extranodal natural killer (NK)/T-cell lymphoma, nasal type (ENKTCL). Five hundred forty patients with stage IE–IIE ENKTCL received chemotherapy (ChT) and/or radiotherapy (RT) in the hospital, and among these, 56 patients who experienced LRR were involved in this investigation. In patients with LRR stage IE–IIE ENKTCL, salvage RT improved survival and the treatment toxicity was acceptable.

Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay